What is the appropriate management after an excisional biopsy of a well-differentiated squamous cell carcinoma with negative surgical margins and negative lymph nodes?

Management After Excisional Biopsy with Negative Margins and Negative Lymph Nodes of Well-Differentiated Squamous Cell Carcinoma

For a well-differentiated cutaneous squamous cell carcinoma that has been completely excised with negative surgical margins and negative lymph nodes, observation with structured surveillance is the appropriate management—no further surgical intervention or adjuvant therapy is required. 1, 2, 3

Rationale for Observation

The achievement of clear surgical margins is the single most critical factor in minimizing risk of local recurrence and metastasis 3. When negative margins are confirmed histologically and lymph nodes are negative, the tumor has been adequately treated. Current evidence does not support adjuvant radiotherapy for patients with high-risk localized cSCC when clear surgical margins have been achieved 2.

Key Principles:

• Negative margins = adequate treatment: The primary goal of cSCC treatment is complete removal with histologically confirmed clear margins 1, 3
• Well-differentiated histology: This represents lower-risk disease compared to poorly differentiated tumors
• Negative lymph nodes: Absence of regional metastatic disease further supports observation

Structured Surveillance Protocol

Follow-up schedule based on European consensus guidelines 2, 3:

Years 1-2:

• Physical examination every 3 months
• Include total body skin examination
• Palpation of regional lymph node basins

Year 3:

• Physical examination every 4 months (3 times yearly)

Years 4-5:

• Physical examination every 6 months (2 times yearly)

Beyond 5 years:

• Annual examinations may be considered, though frequency depends on individual risk factors

What to Monitor During Follow-Up

At each visit, specifically assess for:

• Local recurrence: Examine the excision site for nodules, induration, or ulceration
• Regional lymphadenopathy: Palpate draining lymph node basins (cervical, axillary, inguinal depending on primary site)
• New primary cSCC: Complete skin examination for additional lesions
• Symptoms: Ask about localized pain, functional changes, or systemic symptoms

Imaging Considerations

Routine imaging is NOT recommended for completely excised, low-risk cSCC with negative margins and nodes 2, 3. Imaging should only be performed if:

• Clinical examination reveals suspicious findings
• Patient develops concerning symptoms
• New palpable lymphadenopathy develops

Important Caveats

When This Approach Does NOT Apply:

1. Positive or close margins: Re-excision should be performed 3, 4, 5

2. High-risk features present: Even with negative margins, certain features may warrant closer surveillance:

   • Tumor depth >6mm (Breslow thickness)
   • Perineural invasion (especially named nerves >0.1mm)
   • Lymphovascular invasion
   • Location on ear, lip, or temple
   • Tumor diameter >2cm
   • Immunosuppressed patients

3. Poorly differentiated or undifferentiated tumors: These require more aggressive surveillance regardless of margin status 2

Margin Interpretation Pitfall

Critical distinction: "Negative margins" must mean tumor-free margins confirmed by histopathology, not simply "no gross residual disease" 1. The pathology report should state:

• Distance of clearance from lateral margins
• Distance of clearance from deep margin
• Absence of tumor at all margins

If the pathology report is ambiguous about margin status, consider requesting clarification or re-excision.

No Role for Adjuvant Therapy

Adjuvant radiotherapy is NOT indicated for completely excised cSCC with clear margins, even in the presence of high-risk features 2. Current evidence has not demonstrated significant benefit for adjuvant radiotherapy in patients with at least one high-risk factor when clear surgical margins have been achieved.

Systemic therapy (anti-PD-1 agents like cemiplimab) is reserved exclusively for:

• Locally advanced unresectable disease
• Regional or distant metastatic disease
• Recurrent disease not amenable to curative surgery or radiotherapy 2, 3

Patient Education

Counsel patients on:

• Sun protection: Daily broad-spectrum sunscreen, protective clothing, avoid peak sun hours
• Self-examination: Monthly skin checks for new or changing lesions
• Prompt reporting: Any changes at the excision site or new lumps in lymph node areas
• Risk of new primaries: Patients with one cSCC have increased risk of developing additional skin cancers